Diabetes drug 'Avandia' to be pulled from shelves

Published: 2010-10-27 07:00:00

Updated: 2010-10-27 07:00:00

U.K.-based GlaxoSmithKline (GSK)’s blockbuster anti-diabetes pill “Avandia” will face being banned in the Korean market as the Korea Food and Drug Administration (KFDA) announced a plan to review the drug once again after much criticism arose regarding its lax monitoring. The meeting will decide on October 29 whether Korea will also shelve the drug.

The drug agency already ordered doctors to...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.